Navigation Links
Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis
Date:5/4/2009

) and Fovea holds an exclusive worldwide license to this intellectual property for ophthalmic indications.

"This study validates both a new clinical technology and new therapeutic approach," said Mark B. Abelson, M.D., Chairman and Chief Scientific Officer of Ora, Inc. "Patients with a history of chronic ocular background inflammation make up a large segment of the ocular allergy market, and are also patients that tend to evolve towards dry eye, another significant ocular disorder. In this study, they have been treated effectively and safely by Prednisporin(TM)."

Allergic conjunctivitis is a frequent disorder. It occurs in up to 90% of patients suffering from allergies and in more than 20% of the global population. In the USA alone, 80 million people experience ocular surface allergy and inflammation. More than 50% of all forms of allergic conjunctivitis have a chronic inflammatory background (persistent allergic conjunctivitis). As current therapies do not address the underlying chronic inflammation, they fail to treat such a disease effectively. Significant opportunities exist for novel products in the ocular allergy market.

Fovea is now preparing pivotal trials for Prednisporin(TM) both in the USA and in Europe with the goal of filing NDA applications late 2010.

About Fovea Pharmaceuticals

Fovea Pharmaceuticals SA (Fovea) is a privately-held biopharmaceutical company specialized in development and commercialization of drugs for the treatment of ocular diseases, with a special focus on retinal pathologies. Founded in May 2005, Fovea has raised euro 50.5m ($69m) in two financing rounds from a strong international syndicate of investors.

Fovea has built a project portfolio including internal research programs on dry AMD, glaucoma (neuroprotection) and retinal dystrophies as well as clinical programs underway for such indications as allergic conjunctivitis, di
'/>"/>

SOURCE Fovea Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... /PRNewswire-iReach/ -- Full Service CRO WCCT Global ... President of Business Development. Peter has been in the ... of different business development positions with some of the ... related to business development/sales management and marketing.  The experience ... him a key and strategic asset to WCCT Global ...
(Date:7/25/2014)... , July 25, 2014  The Chemistry, ... Tobago Ministry of Health approved the introduction of ... increases the cure rate from Hepatitis C, and ... genotype 1 virus. Telaprevir is available in ... INCIVO®. Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg   ...
(Date:7/25/2014)... , July 25, 2014  Solanbridge Group Inc ... acquired the majority interest in Buzznbrewz.com and the Letter ... replaced with a fully executed Purchase Agreement. ... stated "We are proud to have Mr. David ... decades of experience in the private sector and developed ...
Breaking Medicine Technology:Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development 2The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2
... , , CHARLOTTESVILLE, Virginia, December ... the 2009 Top Innovator Presentation Award,in Healthcare, at the ... Dedham, MA. The award, which recognizes cutting edge private ... who competed with,over 50 other privately held companies that ...
... , ... CVS/pharmacy and MinuteClinic health care centers located in select ... and Washington, D.C. While in some locations priority restrictions ... allowing all patients to be eligible to receive the shot ...
Cached Medicine Technology:Biovista Inc. Named Top Innovator in Life Sciences 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4
(Date:7/28/2014)... new study of the European project SOPHIE has ... policies and gender inequalities in health in Europe. ... policies (central and southern Europe) and countries with ... self-perceived health, i.e. women reported poorer health than ... Europe countries, where women present a 27% higher ...
(Date:7/28/2014)... Termed by the Michigan Osteopathic Association ... fatal overdoses than heroin and cocaine combined, and takes ... are particularly vulnerable to succumbing to prescription overdose are ... in this age group taking at least seven different ... reawakened in the White House in the midst of ...
(Date:7/28/2014)... Karen Pallarito HealthDay ... U.S. taxpayers who go without health insurance this year will ... for a family of five, the Internal Revenue Service says. ... on the federal tax penalties that some Americans will owe ... cap is based on the monthly national average premium for ...
(Date:7/28/2014)... PA (PRWEB) July 28, 2014 "We ... kept shutting," said one of two inventors from Jamestown, ... the lids open so that we could pour medications ... the CONKLIN'S STAY OPEN to keep the lids open ... lids from closing until all compartments have been filled. ...
(Date:7/28/2014)... Community Health Center of Snohomish County (CHC), ... services, has released an article designed to educate patients ... Founded in 1983, the health center has a strong ... that face barriers to obtaining high quality yet affordable ... the CHC, click here: http://www.chcsno.org/locations.ashx?p=1099 , The ...
Breaking Medicine News(10 mins):Health News:Gender inequalities in health: A matter of policies 2Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 2Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 3Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 4Health News:IRS Caps Fines on Uninsured Americans at $12K for Family of 5 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 3
... DURHAM, N.C. By targeting and disabling a protein ... to make the cancer more vulnerable to chemotherapy, according ... researchers in the Duke Comprehensive Cancer Center. , "In ... melanoma a compound that had been shown in pre-clinical ...
... BURLINGTON, Mass., March 6 Palomar Medical Technologies, Inc. ... developer of light-based systems for cosmetic treatments, announced today ... XD Optic(TM), the GROOVE Optic(TM), LuxPowR(TM) pulsed-light handpiece and ... the 67th Annual Meeting of the American Academy of ...
... March 6 ALOKA Co., Ltd. will be unveiling ... of Radiology - ECR2009 - to be held from ... generate demand for ultrasound systems with higher cost-effectiveness, flexibility, ... is a stand-alone, black-and-white system with the latest digital ...
... in German . , The combination ... of certain brain tumours. This has been demonstrated by researchers ... colleagues in a current study. They treated 39 patients who ... on average 23 months; with the standard therapy the mean ...
... cardiovascular nurse and allied professional are already at the ... disease, and Professor Christi Deaton, Chairperson of the ESC ... an even greater role given the complex needs of ... to prevent cardiovascular disease," says Professor Deaton, "and we ...
... colorectal cancer and removal of precancerous polyps among key ... Brook, Ill., March 6 /PRNewswire-USNewswire/ -- Colorectal ... of the most preventable cancers. Recent statistics show that ... diagnosed) and death rates from colorectal cancer are declining, ...
Cached Medicine News:Health News:Drug combination may be effective against deadly melanoma, pilot study shows 2Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 2Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 3Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 4Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 5Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 6Health News:ALOKA Showcases a New Diagnostic Ultrasound System ProSound 4 at ECR 2009 in Vienna, Austria 2Health News:Brain tumors: New therapy surprisingly successful 2Health News:Nurses and allied professionals at heart of cardiovascular prevention and management programs 2Health News:Nurses and allied professionals at heart of cardiovascular prevention and management programs 3Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 2Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 3Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 4Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 5Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 6Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 7
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
Medicine Products: